KORU Medical Systems KRMD Income Statement (2010-2026)

NASDAQ KRMD
$3.15 +0.00 (+0.16%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

KORU Medical Systems Quarterly Income Statement

Periods 44 quarters
Latest Jun 2026

KORU Medical Systems reported revenue of $12.05M and net income of $0.25M for the quarter ended Jun 2026, up 18.2% year over year. This income statement covers 44 quarters of results from Aug 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Feb2015 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
6.04M6.49M6.24M6.55M7.76M7.34M7.39M6.94M7.00M7.19M8.20M8.43M8.18M8.84M9.64M10.19M10.40M10.90M11.76M12.05M
Cost of RevenueCost of Rev
2.54M2.66M2.62M3.20M3.44M3.27M3.25M3.05M2.66M2.85M3.09M2.95M2.99M3.28M3.59M3.72M4.14M4.08M4.53M4.20M
Gross Profit
3.50M3.83M3.62M3.35M4.32M4.08M4.15M3.89M4.34M4.33M5.10M5.48M5.19M5.56M6.05M6.48M6.26M6.82M7.23M7.85M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.10M0.09M0.11M0.15M0.20M0.21M0.20M0.21M0.22M0.23M
Research & DevelopmentR&D
0.80M0.95M1.15M1.30M0.86M1.64M1.56M1.60M1.29M1.29M1.48M1.13M1.53M1.11M1.11M1.19M0.93M1.14M1.32M1.07M
Selling, General & AdministrativeSG&A
3.90M4.88M5.49M5.53M4.83M4.76M5.43M5.30M4.62M5.01M5.36M5.32M5.13M5.83M5.96M5.38M5.99M6.04M6.58M5.94M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
273.000.02M0.02M0.02M0.19M-0.06M-0.00M-1.00-300.00-0.02M0.22M0.21M0.20M0.18M0.20M-0.41M
Operating ExpensesOpex
4.82M5.94M6.75M6.96M5.85M6.59M7.20M7.11M6.13M6.53M7.06M6.67M6.89M7.15M7.29M6.79M7.13M7.36M8.10M7.22M
Operating IncomeOp. Inc
-1.32M-2.11M-3.13M-3.61M-1.53M-2.51M-3.06M-3.22M-1.79M-2.20M-1.96M-1.19M-1.70M-1.59M-1.25M-0.31M-0.87M-0.55M-0.86M0.63M
EBIT
-1.32M-2.11M-3.13M-3.61M-1.53M-2.51M-3.06M-3.22M-1.79M-2.20M-1.96M-1.19M-1.70M-1.59M-1.25M-0.31M-0.87M-0.55M-0.86M0.63M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
0.11M0.08M0.07M0.08M0.07M0.07M0.08M0.06M
Other Non Operating IncomeOther Non Op Inc.
-0.01M-0.01M-0.01M-0.02M0.04M0.10M0.13M0.13M0.14M0.17M0.04M0.21M0.01M-0.03M0.01M0.04M0.01M-0.01M-0.02M-0.02M
Non Operating IncomeNon Op. Inc.
-0.01M0.67M-0.01M-0.02M0.03M0.10M0.07M0.13M0.12M0.18M0.03M0.20M0.12M0.03M0.08M0.12M0.09M0.06M0.06M-0.37M
Net income details
EBT
-1.33M-1.44M-3.14M-3.63M-1.50M-2.41M-2.99M-3.10M-1.67M-2.02M-1.94M-0.99M-1.58M-1.56M-1.17M-0.19M-0.78M-0.48M-0.81M0.26M
Tax ProvisionsTaxes
-0.24M-0.38M-0.60M-0.71M-0.27M3.82M-0.58M-0.60M-0.30M5.45M0.02M-150.000.53M0.01M
Profit After TaxPAT
-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.49M-0.81M0.25M
Income from Continuing OperationsIncome (Continuing)
-1.09M-1.07M-2.54M-2.92M-1.23M-6.23M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-1.01M-0.81M0.25M
Consolidated Net IncomeConsol Net Inc.
-1.09M-1.07M-2.54M-2.92M-1.23M-6.23M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-1.01M-0.81M0.25M
Income towards Parent CompanyParent Net Inc
-1.09M-1.07M-2.54M-2.92M-1.23M-6.23M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-1.01M-0.81M0.25M
Net Income towards Common StockholdersNet Income
-1.09M-1.07M-2.54M-2.92M-1.23M-6.23M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-1.01M-0.81M0.25M
Additional items
EPS (Basic)
-0.02-0.02-0.06-0.07-0.03-0.14-0.05-0.05-0.03-0.16-0.04-0.02-0.03-0.03-0.030.00-0.02-0.02-0.020.01
EPS (Diluted)
-0.02-0.02-0.06-0.07-0.03-0.14-0.05-0.05-0.03-0.16-0.04-0.02-0.03-0.03-0.030.00-0.02-0.02-0.020.01
Shares Outstanding
44.32M44.39M44.67M44.92M45.04M45.00M45.49M45.61M45.64M45.60M45.71M45.81M45.85M45.80M45.98M46.19M46.19M46.19M46.36M46.08M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
44.32M44.39M44.67M44.92M45.04M45.00M45.49M45.61M45.64M45.60M45.71M45.81M45.85M45.80M45.98M46.19M46.24M46.19M46.36M49.51M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
44.51M44.62M44.70M44.99M45.24M45.44M45.54M45.61M45.64M45.67M45.72M45.82M45.84M45.96M46.14M46.23M46.29M46.37M46.13M46.15M
EBITDA
-1.22M-2.11M-3.03M-3.50M-1.38M-2.51M-2.86M-3.01M-1.59M-2.20M-1.75M-0.97M-1.48M-1.59M-1.25M-0.31M-0.87M-0.55M-0.86M0.63M
Interest ExpensesInt Expense
Tax Rate
17.88%26.02%19.06%19.56%18.14%-158.46%19.32%19.38%17.99%-269.44%-9.16%0.02%-110.37%2.25%